Status:

COMPLETED

Hepassocin Levels in Patients With Polycystic Ovary Syndrome

Lead Sponsor:

Fatma ketenci gencer

Conditions:

Hepassocin (Hepatocyte-derived Fibrinogen-related Protein 1)

Polycystic Ovary Syndrome

Eligibility:

FEMALE

18-35 years

Brief Summary

The investigators aimed to investigate hepassocin levels in patients with polycystic ovary syndrome (PCOS). There are 3 groups aged between 18 and 35 years as non-obese healthy women, non-obese women ...

Detailed Description

Hepassocin, also known as Fibrinogen-like-protein or hepatocyte-derived fibrinogen-related protein 1, is a new marker for obesity and insulin resistance. In hepatic injury, it protects liver cells and...

Eligibility Criteria

Inclusion

  • 60 patients with PCOS aged between 18 and 35 and age-matched 30 healthy women with BMI\<30

Exclusion

  • Premature ovarian failure (FSH \>30 mIU/mL), tumors secreting androgens, non-classical congenital adrenal hyperplasia, Cushing syndrome and irregular menses due to thyroid dysfunction (TSH \>5 mIU/L ), hyperprolactinemia, more than twofold high transaminase levels (\>70 U/L), patients with cigarette smoking, alcohol consumption, oral contraceptives use, medications that are affecting liver function test, insulin metabolism and lipid metabolism, patients with a history of chronic diseases such as diabetes mellitus, hypertension, chronic liver disease, chronic kidney disease, autoimmune disease, inflammatory disease, malignant disease, bleeding disorders, and thrombosis were also excluded. All the patients were beta-HCG, hepatitis B surface antigen, and hepatitis C antibody negative.
  • \-

Key Trial Info

Start Date :

January 3 2020

Trial Type :

OBSERVATIONAL

Allocation :

ACTUAL

End Date :

March 25 2020

Estimated Enrollment :

90 Patients enrolled

Trial Details

Trial ID

NCT04369248

Start Date

January 3 2020

End Date

March 25 2020

Last Update

April 30 2020

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Gaziosmanpasa Taksim Education and Research Hospital

Istanbul, Turkey (Türkiye)